Danaparoid: an anti-thrombotic agent without major impact on triglyceride hydrolysis capacity in humans.
Mikhailidis
D P
DP
Jagroop
I A
IA
D000925:Anticoagulants / Q000494:pharmacology*; D000990:Antithrombin III / Q000494:pharmacology*; D002809:Chondroitin Sulfates / Q000494:pharmacology*; D003871:Dermatan Sulfate / Q000494:pharmacology*; D004338:Drug Combinations; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006496:Heparinoids / Q000494:pharmacology*; D006497:Heparan Sulfate / Q000494:pharmacology*; D006801:Humans; D006868:Hydrolysis / Q000187:drug effects; D014280:Triglycerides / Q000378:metabolism*
D000925:Anticoagulants; D000990:Antithrombin III; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D005230:Fatty Acids, Nonesterified; D006496:Heparinoids; D006497:Heparan Sulfate; D014280:Triglycerides; C035838:danaparoid